Abstract
During the last century, our battle against cancer has been inaugurated upon three main approaches; surgery, radiation and chemotherapy. The latest findings on the effectiveness of immunotherapy in cancer management offer a ray of hope after decades of research and studies on the best treatment methods. Immunotherapy has proven effective in the surveillance and destruction of cancer- causing cells, demonstrating its ability to suppress cancer through controlling the wellestablished immune-editing process. Immuno-editing is a process that comprises three principal elements; elimination, equilibrium, and escape, and is paramount to the comprehension of checkpoint inhibition. Cancer cells employ various approaches to evade the elimination step leading to its immune- escape. The escape mechanism encompasses the up-regulation of negative co-signals that block successful activation of cancer-eradicating immune cells, developing cytokine background that favors the immunosuppressive tumor microenvironment (TME), or dropping the expression of tumor- specific proteins known as neo-antigens, therefore reducing the immunogenic activity against cancer cells. Today, checkpoint inhibitors are considered as a primary approach in our fight against cancer. Strategies targeting the inhibitory roles of checkpoint inhibitors have been shown effective against different cancer types and stages, and some already gained the FDA’s approval. This review seeks to comprehensively cover the historical background as well as the most recent updates for the role of immune checkpoint regulators in the maintenance of immune homeostatic balance as well as keeping the tumorigenic cells in check.
Keywords: Cancer immunotherapy, checkpoint stimulators, checkpoint inhibitors, immuno-surveillance, tumor microenvironment, PD-1, CTLA-4, SIRPα/CD47.
Graphical Abstract
Current Cancer Drug Targets
Title:Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy
Volume: 20 Issue: 6
Author(s): Mohammed Shaaban, Heba Othman, Takwa Ibrahim, Mariam Ali, Mohamed Abdelmoaty, Abdel-Rahman Abdel-Kawi, Ahmed Mostafa, Aya El Nakeeb, Heba Emam and Alaa Refaat*
Affiliation:
- Scientific Research Center, MISR International University, Cairo,Egypt
Keywords: Cancer immunotherapy, checkpoint stimulators, checkpoint inhibitors, immuno-surveillance, tumor microenvironment, PD-1, CTLA-4, SIRPα/CD47.
Abstract: During the last century, our battle against cancer has been inaugurated upon three main approaches; surgery, radiation and chemotherapy. The latest findings on the effectiveness of immunotherapy in cancer management offer a ray of hope after decades of research and studies on the best treatment methods. Immunotherapy has proven effective in the surveillance and destruction of cancer- causing cells, demonstrating its ability to suppress cancer through controlling the wellestablished immune-editing process. Immuno-editing is a process that comprises three principal elements; elimination, equilibrium, and escape, and is paramount to the comprehension of checkpoint inhibition. Cancer cells employ various approaches to evade the elimination step leading to its immune- escape. The escape mechanism encompasses the up-regulation of negative co-signals that block successful activation of cancer-eradicating immune cells, developing cytokine background that favors the immunosuppressive tumor microenvironment (TME), or dropping the expression of tumor- specific proteins known as neo-antigens, therefore reducing the immunogenic activity against cancer cells. Today, checkpoint inhibitors are considered as a primary approach in our fight against cancer. Strategies targeting the inhibitory roles of checkpoint inhibitors have been shown effective against different cancer types and stages, and some already gained the FDA’s approval. This review seeks to comprehensively cover the historical background as well as the most recent updates for the role of immune checkpoint regulators in the maintenance of immune homeostatic balance as well as keeping the tumorigenic cells in check.
Export Options
About this article
Cite this article as:
Shaaban Mohammed , Othman Heba , Ibrahim Takwa , Ali Mariam, Abdelmoaty Mohamed , Abdel-Kawi Abdel-Rahman , Mostafa Ahmed , El Nakeeb Aya , Emam Heba and Refaat Alaa *, Immune Checkpoint Regulators: A New Era Toward Promising Cancer Therapy, Current Cancer Drug Targets 2020; 20 (6) . https://dx.doi.org/10.2174/1568009620666200422081912
DOI https://dx.doi.org/10.2174/1568009620666200422081912 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Related Books
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antioxidant and Antimicrobial Activities of Cinnamic Acid Derivatives
Mini-Reviews in Medicinal Chemistry Chemistry, Stability and Bioavailability of Resveratrol
Medicinal Chemistry Iron Chelators in Cancer Chemotherapy
Current Topics in Medicinal Chemistry Synthesis and Antiproliferative Evaluation of Spirothiadiazolopyridazine Derivatives
Letters in Drug Design & Discovery Advances in Anticancer Antibody-Drug Conjugates and Immunotoxins
Recent Patents on Anti-Cancer Drug Discovery Drug Metabolism and Pharmacokinetics of Dammarane Triterpenoids
Current Drug Metabolism A Novel Method to Synthesize 4-Aryl-1H-1,2,3-Triazoles and its Antihepatoma Activity
Anti-Cancer Agents in Medicinal Chemistry A Novel Method for the Analysis of Soluble Carbohydrates from Cistanche deserticola
Current Analytical Chemistry Bacterial Protein Microarrays for Diagnosis of Infectious Diseases
Current Immunology Reviews (Discontinued) A Tropical Lichen, Dirinaria consimilis Selectively Induces Apoptosis in MCF-7 Cells through the Regulation of p53 and Caspase-Cascade Pathway
Anti-Cancer Agents in Medicinal Chemistry Insulin-Like Growth Factor-1, a Potential Predicative Biomarker for Postoperative Delirium Among Elderly Patients with Open Abdominal Surgery
Current Pharmaceutical Design An Update to the Combined Vibrational- Diffraction Experimental and Theoretical Studies of Small Biologically Important Cyclic Imides:Reference to Saccharin
Current Organic Chemistry Biological Network Derivation by Positive Unlabeled Learning Algorithms
Current Bioinformatics Genome-Scale Metabolic Model as a Virtual Platform to Reveal the Environmental Contribution of Methanogens
Current Biotechnology Nutritional Metabolomics: Lessons from Companion Animals
Current Metabolomics Bioprospecting of <i>Brevibacillus brevis</i> Isolated from Soil
Recent Patents on Biotechnology Multivariate Calibration Applied to the Simultaneous Spectrophotometric Determination of Ascorbic Acid, Tyrosine and Epinephrine in Pharmaceutical Formulation and Biological Fluids
Current Analytical Chemistry Roles of UDP-Glucuronosyltransferases in Phytochemical Metabolism of Herbal Medicines and the Associated Herb-Drug Interactions
Current Drug Metabolism Recent Advances in Bipolar Electrochemiluminescence for Analytical Application
Current Analytical Chemistry The Endocannabinoid System in Ageing: A New Target for Drug Development
Current Drug Targets